SCHEMBL26066952

SCHEMBL26066952

COc1ccc(C(NCCCC[C@@H](C)NC(=O)COCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCN)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.39
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC7 Q8WUI4 1/20 0.36
▸ ADORA3 P0DMS8 1/20 0.36
▸ KIF11 P52732 5/20 0.36
▸ TSHR P16473 1/20 0.35
▸ RECQL P46063 1/20 0.35
▸ PTPN1 P18031 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ EPOR P19235 1/20 0.35
▸ KCNH2 Q12809 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ ACHE P22303 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25218460 0.84 HDAC8 (0.36) HDAC1HDAC7
SCHEMBL26066853 0.84 HDAC8 (0.39) HDAC1HDAC7EPOR
SCHEMBL26066857 0.84 HDAC8 (0.39) HDAC1HDAC7EPOR
SCHEMBL26067020 0.81 NPY1R (0.33) HDAC1HDAC7ADORA3KIF11EPOR
SCHEMBL26067006 0.79 KIF11 (0.39) KIF11TSHRRECQLSMN1; SMN2
SCHEMBL5973130 0.76 KIF11 (0.51) KIF11KCNH2SMN1; SMN2
SCHEMBL21118854 0.75 FOLH1 (0.36) HDAC1HDAC7
SCHEMBL25245450 0.74 FOLH1 (0.35) HDAC1HDAC7
SCHEMBL25242026 0.74 FOLH1 (0.37) HDAC1HDAC7
SCHEMBL25242024 0.74 FOLH1 (0.37) HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230270867-A1 CONJUGATE IN WHICH FL118 DRUG IS LINKED TO ACID-SENSITIVE LINKER, AND IMMUNOCONJUGATE USING SAME PINOTBIO, INC. (KR) 2023-08-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230270867-A1 CONJUGATE IN WHICH FL118 DRUG IS LINKED TO ACID-SENSITIVE LINKER, AND IMMUNOCONJUGATE USING SAME SLC46A1, SLC47A1, FOLR1 ALDH1A1 549/4885HDAC1 3656/4885HDAC7 1807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback